AB-101-001 is a Phase 1a/1b double-blind, randomized, placebo-controlled clinical trial designed to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single- ...

The seropositive patients were divided into three groups according to rickettsial antibody titre. Group A (n=13) consisted of patients who had seroconverted (serology changing from seronegative to ...

Diarrhea, which is caused by bacteria such as Salmonella or by viruses like norovirus, is the fourth leading cause of death among children worldwide, with children in low-resource settings being at ...